GENEVA (Kyodo) -- The World Health Organization said Tuesday it has granted emergency use of a Japanese mpox vaccine, its second approval of a product to inoculate against the infectious disease, to combat a recent outbreak mainly in Africa.
The approval of the vaccine, developed by KM Biologics, a group firm of food and pharmaceutical company Meiji Holdings, follows the acceptance of a vaccine manufactured by Bavarian Nordic A/S of Denmark in September.
